References
- Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59
- Brown TH. The rapidly growing mycobacteria- Mycobacterium fortuitum and Mycobacterium chelonei. Infect Control 1985;6:283-8 https://doi.org/10.1017/S0195941700061762
- Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657- 79 https://doi.org/10.1093/clinids/5.4.657
- Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8 https://doi.org/10.1378/chest.129.2.341
- Awe RJ, Gangadharam PR, Jenkins DE. Clinical significance of Mycobacterium fortuitum infections in pulmonary disease. Am Rev Respir Dis 1973;108:1230-4
- Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-8 https://doi.org/10.1164/ajrccm/147.5.1271
- Park S, Suh GY, Chung MP, Kim H, Kwon OJ, Lee KS, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008; 102:437-42 https://doi.org/10.1016/j.rmed.2007.10.005
- Lee SM, Kim J, Jeong J, Park YK, Bai GH, Lee EY, et al. Evaluation of the broth microdilution method using 2, 3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. J Korean Med Sci 2007;22:784-90 https://doi.org/10.3346/jkms.2007.22.5.784
- Daley CL, Griffith DE. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002;23: 623-32, vii https://doi.org/10.1016/S0272-5231(02)00021-7
- Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416 https://doi.org/10.1164/rccm.200604-571ST
- Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002;15:716-46 https://doi.org/10.1128/CMR.15.4.716-746.2002
- Vadakekalam J, Ward MJ. Mycobacterium fortuitum lung abscess treated with ciprofloxacin. Thorax 1991; 46:737-8 https://doi.org/10.1136/thx.46.10.737
- Tasaka S, Urano T, Mori M, Yamaguchi K, Kanazawa M. A case of Mycobacterium fortuitum pulmonary disease in a healthy young woman successfully treated with ciprofloxacin and doxycycline. Kekkaku 1995;70: 31-5
- Ichiyama S, Tsukamura M. Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum. Chest 1987;92:1110-2 https://doi.org/10.1378/chest.92.6.1110
- American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1-25 https://doi.org/10.1164/ajrccm.156.1.ed08-97
- Kim SJ, Hong YP, Bai GH, Kim SC, Jin BW. Nontuberculous pulmonary infection in two patients with Mycobacterium avium-intracellulare complex and a patient with M. fortuitum. J Korean Soc Microbiol 1982; 17:87-93